Pages that link to "Q36760641"

The following pages link to A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain (Q36760641):

Displaying 29 items.

• Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics (Q28213511) (← links)
• Activity-dependent changes in synaptophysin immunoreactivity in hippocampus, piriform cortex, and entorhinal cortex of the rat (Q28576508) (← links)
• High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation (Q29616564) (← links)
• The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease (Q33768345) (← links)
• Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice (Q34625154) (← links)
• Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease (Q35745700) (← links)
• Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia (Q36318191) (← links)
• Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability (Q37326829) (← links)
• Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury (Q38298161) (← links)
• Diagnosis and Staging of Alzheimer Disease (Q41612700) (← links)
• Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice (Q41674335) (← links)
• Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). (Q43825281) (← links)
• Synaptic proteins, neuropathology and cognitive status in the oldest-old. (Q45983897) (← links)
• Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. (Q46035669) (← links)
• Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis (Q46162628) (← links)
• Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease (Q46372282) (← links)
• Is DNA repair compromised in Alzheimer's disease? (Q46444487) (← links)
• The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease (Q46497293) (← links)
• The Lewy body variant of Alzheimer disease (Q46642150) (← links)
• Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury (Q46741098) (← links)
• Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age. (Q48483805) (← links)
• Synaptic numbers across cortical laminae and cognitive performance of the rat during ageing (Q48491792) (← links)
• Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity (Q48643767) (← links)
• Effects of soft-diet feeding on synaptic density in the hippocampus and parietal cortex of senescence-accelerated mice (Q48862001) (← links)
• Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease (Q48865828) (← links)
• Perinatal asphyxia results in changes in presynaptic bouton number in striatum and cerebral cortex-a stereological and behavioral analysis (Q52023309) (← links)
• Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. (Q53235363) (← links)
• Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia (Q73331970) (← links)
• Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology (Q77227270) (← links)